
Direxion Daily S&P Biotech Bear 3X Shares (LABD)
AMEX
Fin d'année 31 Octobre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -0.139 | 0.553 | -32.486 | -108.37 | -128.135 | -12.142 | 26.268 | -66.719 |
Return on Equity (%) | -0.192 | 0.714 | -36.401 | -125.291 | -154.405 | -13.986 | 32.369 | -85.691 |
Return on Invested Capital (%) | -1.391 | 1.803 | 2.66 | -0.149 | -2.047 | -17.769 | 13.583 | 6.404 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 5.044 | 39.188 | 20.405 | 54.512 | 21.33 | 20.176 | 26.737 | 6.17 |
Earnings Per Share | -0.009 | 0.385 | -6.249 | -78.386 | -38.611 | -1.762 | 17.603 | -4.746 |
Cash Per Share | 1.795 | 21.427 | 7.958 | 27.081 | N/A | N/A | N/A | N/A |
Working Capital Per Share | 0.162 | 39.188 | 9.549 | 54.512 | 1.778 | -1.199 | 26.737 | 6.17 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | -0.009 | 0.665 | -5.893 | -78.063 | -38.611 | -1.762 | 19.071 | -4.405 |
Fin d'année 31 Octobre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 19,5M | 1,43M | 4,04M | 1,17M | 2,22M | 9,42M | 2,32M | 12,62M |
Fin d'année 31 Octobre 2024 | ||||||||
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | |||||||
Return on Assets (%) | N/A | |||||||
Return on Equity (%) | N/A | |||||||
Return on Invested Capital (%) | N/A | |||||||
Operating Margin (%) | N/A | |||||||
Net Profit Margin (%) | N/A | |||||||
Sales Per Share | N/A | |||||||
Book Value Per Share | N/A | |||||||
Earnings Per Share | N/A | |||||||
Cash Per Share | N/A | |||||||
Working Capital Per Share | N/A | |||||||
Operating Profit Per Share | N/A | |||||||
EBIT Per Share | N/A | |||||||
EBITDA Per Share | N/A | |||||||
Free Cash Flow Per Share | N/A | |||||||
Current Ratio | N/A | |||||||
Quick Ratio | N/A | |||||||
Inventory Turnover (Days) | N/A |
Capitalisation boursière | 98,53M |
Ratio cours/bénéfice | -1,63 |
Ratio prix/ventes | 16,4 |
Ratio prix/liquidités | 0 |
Ratio prix/valeur comptable | 1,26 |
Rendement de dividende | 386,10% |
Actions en circulation | 12,62M |
Volume moyen (1 semaine) | 11,94M |
Volume moyen (1 mois) | 17,03M |
Variation sur 52 semaines | 23,33% |
Plus haut sur 52 semaines | 11,41 |
Plus bas sur 52 semaines | 4,78 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales